CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)
- 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $63.88 ($319,384)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $66.12 ($462,830)
- 4 Open-market sale Chief Executive Officer sold 1,729 shares at $41.30 ($71,408)
- 4 Open-market sale Senior Vice President, Finance sold 395 shares at $41.30 ($16,314)
- 4 Open-market sale Chief Operating Officer sold 600 shares at $41.30 ($24,780)
- 4 Planned sale Chief Medical Officer sold 7,641 shares at an average $40.91 ($312,560)
- 4 Open-market sale General Counsel sold 733 shares at $41.30 ($30,273)
- 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $33.56 ($167,822)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $32.37 ($226,559)
- 4 Grant or award Chief Medical Officer acquired 32,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 32,500 shares (grant or award)
- 4 Grant or award SVP, Finance acquired 17,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 76,700 shares (grant or award)
- 4 Grant or award General Counsel acquired 32,500 shares (grant or award)
- 4 Other acquisition Director acquired 116,483 shares (other)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $31.81 ($222,704)
- 4 Planned sale Chief Operating Officer sold 13,000 shares at an average $28.52 ($370,795)
- 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $30.61 ($214,293)
- 4 Derivatives Options or other derivatives
Page 3 of 23 · 459 filings